Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 938-944, May 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dingman, C. W.
Right arrow Articles by Sporn, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dingman, C. W.
Right arrow Articles by Sporn, M. B.

The Binding of Metabolites of Aminoazo Dyes to Rat Liver DNA in Vivo

C. Wesley Dingman and Michael B. Sporn

Chemistry Branch, National Cancer Institute, NIH, Bethesda, Maryland 20014

The binding of isotopically labeled aminoazo dye metabolites to rat liver DNA and protein in vivo was investigated. Both benzenoid ring systems of 4-dimethylaminoazobenzene (DAB) bind to DNA. When rats were prefed a high riboflavin diet (which inhibits carcinogenesis by DAB), less binding of DAB metabolites to both DNA and protein was observed. However, the inhibition of binding to DNA resulting from a high riboflavin diet was significantly greater than the inhibition of binding to protein.

The binding of metabolites of the carcinogenic aminoazo dye 3'-methyl-4-dimethylaminoazobenzene to DNA in vivo was found to be 6 times greater than that observed with the noncarcinogenic dye 2-methyl-4-dimethylaminoazobenzene and 9 times greater than that observed with another noncarcinogenic dye, 3'-trifluoromethyl-4-dimethylaminoazobenzene.

These findings support the proposal that binding to DNA by a compound may be necessary to initiate carcinogenesis.

Received 8/17/66. Accepted 1/ 4/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.